Chairman and Managing Director
Dr. Cyrus Poonawalla, Chairman of Poonawalla Group which includes the privately owned Serum Institute of India, India's top biotech company and the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses).
By 1974 Serum Institute introduced the DTP vaccine, which protects children from diphtheria, tetanus and pertussis, followed by an anti-snake-venom serum for snakebites in 1981.
In 1989 Serum Institute began the production of its Measles Vaccine M-Vac and within a year Serum Institute became the country's largest vaccine manufacturer. In the 80s India was made self-sufficient for Tetanus, Diphtheria and Whooping Cough vaccines thanks to the production from Serum Institute.
In 1994, Serum Institute got accredited by the World Health Organization (WHO) to export vaccines from India and started supplying high quality vaccines to U.N. Agencies such as UNICEF (United Nations Children's Fund), PAHO (Pan American Health Organization).
From the inception, Dr. Poonawalla’s primary concept was not only to make life-saving drugs and vaccines, which were in shortage in the country, but also to see that every child was protected. At that time his dictum was "Health for all by 2000 AD". The resultant effort was the National Program of Immunization, which is largely dependent on the vaccines manufactured by Serum Institute and now that philosophy has proliferated worldwide to International U.N. Agencies.
Dr. Poonawalla’s strong belief in "No Compromise with Quality" and willful commitment in "Health for All with affordable Vaccines” has today lead Serum Institute to become India’s leading biotech company and has now clearly emerged as the world's largest vaccine manufacturer by number of doses produced and sold (more than 1.3 billion doses) which includes Polio vaccine.
CEO - Serum Institute Of India Pvt.Ltd
Adar Poonawalla (born 14 January 1981) is the chief executive officer (CEO) and executive director of Serum Institute of India. Founded in 1966 by his father, Dr. Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.
Adar Poonawalla joined Serum Institute in 2001 after graduating from the University of Westminster in London. Then exporting its products to 35 countries, Poonawalla concentrated on the company's international market and getting new products licensed and pre-qualified by the World Health Organization for supply to United Nations Agencies includiing UNICEF and PAHO. As of 2015, the company now exports its products to over 140 countries. 85 percent of its revenues are from overseas.
In 2011 he became the CEO of Serum Institute of India with full control of day-to-day operations of the company. In 2012 he played a major role in the acquisition of Bilthoven Biologicals a Netherlands-based government vaccine manufacturing company. Poonawalla is a board member of the GAVI Alliance, the global Vaccine Alliance.
He initiated and launched Serum Institute’s Oral Polio Vaccine in 2014, which went on to become a bestseller for the company and every year plans to launch a new vaccines for public health starting from 2017. In 2014, it was reported that he planned to expand the product portfolio to include vaccines for dengue, flu and cervical cancer.
In 2013 he hosted Charles, Prince of Wales and The Duchess of Cornwall during a private visit to Serum Institute's manufacturing facility in India.
In 2016, he was selected by Economic Times as Business Leader under the age of 40.
He was also listed by GQ magazine as one of the 50 most influential young indians and also was awarded Philanthropist of the year 2016.
On 7th Jan 2016 he launched www.adarpcleancity.com a city wide initiative where he committed & spent 20 million dollars to cleanup the city of pune using hundreds of trucks, Glutton machines and bins across the city under his personal management & dedicated team.
Address - 16-B/1, Dr. Ambedkar Road, Sarosh Bhavan, Pune, Maharashtra 411001, India
Phone No - 020 2613 7221